• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越张力:疾病异质性中心的α-突触核蛋白的分子多样性。

Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity.

机构信息

Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.

出版信息

Int J Mol Sci. 2023 Aug 25;24(17):13199. doi: 10.3390/ijms241713199.

DOI:10.3390/ijms241713199
PMID:37686005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10487421/
Abstract

Alpha-synucleinopathies (α-synucleinopathies) such as Parkinson's disease (PD), Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are all characterized by aggregates of alpha-synuclein (α-syn), but display heterogeneous clinical and pathological phenotypes. The mechanism underlying this heterogeneity is thought to be due to diversity in the α-syn strains present across the diseases. α-syn obtained from the post-mortem brain of patients who lived with these conditions is heterogenous, and displays a different protease sensitivity, ultrastructure, cytotoxicity, and seeding potential. The primary aim of this review is to summarize previous studies investigating these concepts, which not only reflect the idea of different syn strains being present, but demonstrate that each property explains a small part of a much larger puzzle. Strains of α-syn appear at the center of the correlation between α-syn properties and the disease phenotype, likely influenced by external factors. There are considerable similarities in the properties of disease-specific α-syn strains, but MSA seems to consistently display more aggressive traits. Elucidating the molecular underpinnings of heterogeneity amongst α-synucleinopathies holds promise for future clinical translation, allowing for the development of personalized medicine approaches tackling the root cause of each α-synucleinopathy.

摘要

α-突触核蛋白病(α-synucleinopathies),如帕金森病(PD)、帕金森病痴呆(PDD)、路易体痴呆(DLB)和多系统萎缩(MSA),其特征均为α-突触核蛋白(α-syn)聚集,但表现出异质性的临床和病理表型。这种异质性的机制被认为是由于疾病中存在的α-syn 菌株多样性所致。从患有这些疾病的患者死后大脑中获得的α-syn 是异质的,并且表现出不同的蛋白酶敏感性、超微结构、细胞毒性和种籽潜力。本综述的主要目的是总结以前研究这些概念的研究,这些研究不仅反映了不同 syn 菌株存在的观点,而且表明每种特性仅解释了更大谜团的一小部分。α-syn 菌株出现在 α-syn 特性与疾病表型之间相关性的中心,可能受到外部因素的影响。特定疾病的 α-syn 菌株的特性有很多相似之处,但 MSA 似乎始终表现出更具侵略性的特征。阐明 α-突触核蛋白病之间异质性的分子基础有望为未来的临床转化提供帮助,从而开发出针对每种 α-突触核蛋白病根本原因的个性化医疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d3/10487421/1ba87bd9a12f/ijms-24-13199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d3/10487421/9d9d07deffbc/ijms-24-13199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d3/10487421/1ba87bd9a12f/ijms-24-13199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d3/10487421/9d9d07deffbc/ijms-24-13199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d3/10487421/1ba87bd9a12f/ijms-24-13199-g002.jpg

相似文献

1
Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity.超越张力:疾病异质性中心的α-突触核蛋白的分子多样性。
Int J Mol Sci. 2023 Aug 25;24(17):13199. doi: 10.3390/ijms241713199.
2
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.患者源性 α-突触核蛋白菌株之间的结构差异决定了帕金森病、多系统萎缩和路易体痴呆的特征。
Acta Neuropathol. 2020 Jun;139(6):977-1000. doi: 10.1007/s00401-020-02157-3. Epub 2020 Apr 30.
3
Structural and Functional Insights into α-Synuclein Fibril Polymorphism.α-突触核蛋白纤维多态性的结构与功能研究进展
Biomolecules. 2021 Sep 28;11(10):1419. doi: 10.3390/biom11101419.
4
ɑ-Synuclein strains and the variable pathologies of synucleinopathies.α-突触核蛋白毒株与突触核蛋白病的多样病理学表现
J Neurochem. 2016 Oct;139 Suppl 1:256-274. doi: 10.1111/jnc.13595. Epub 2016 Mar 30.
5
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.新型抗体可检测突触核蛋白病中额外的 α-突触核蛋白病理:免疫治疗的潜在发展。
Alzheimers Res Ther. 2020 Nov 30;12(1):159. doi: 10.1186/s13195-020-00727-x.
6
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.α-突触核蛋白纤维在局部和全身给药后会引起不同的突触核蛋白病。
Nature. 2015 Jun 18;522(7556):340-4. doi: 10.1038/nature14547. Epub 2015 Jun 10.
7
Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.死后脑脊液中的α-突触核蛋白水平在多系统萎缩中升高,并将其与其他α-突触核蛋白病、帕金森病和路易体痴呆区分开来。
Neurobiol Dis. 2012 Jan;45(1):188-95. doi: 10.1016/j.nbd.2011.08.003. Epub 2011 Aug 10.
8
Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.α-突触核蛋白特异性 scFv 抗体的纤维形式抑制α-突触核蛋白种子诱导的聚集和毒性。
Sci Rep. 2020 May 18;10(1):8137. doi: 10.1038/s41598-020-65035-8.
9
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.α-突触核蛋白构象揭示了与 α-突触核蛋白病临床异质性的联系。
Transl Neurodegener. 2023 Mar 14;12(1):12. doi: 10.1186/s40035-023-00342-4.
10
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.不同的 α-突触核蛋白菌株及其对 α-突触核蛋白病异质性的影响。
Neurobiol Dis. 2018 Jan;109(Pt B):209-218. doi: 10.1016/j.nbd.2017.07.018. Epub 2017 Jul 24.

引用本文的文献

1
Novel in situ seeding immunodetection assay uncovers neuronal-driven alpha-synuclein seeding in Parkinson's disease.新型原位接种免疫检测法揭示帕金森病中神经元驱动的α-突触核蛋白种子形成。
NPJ Parkinsons Dis. 2025 Aug 25;11(1):259. doi: 10.1038/s41531-025-01111-y.
2
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.α-突触核蛋白种子扩增检测在突触核蛋白病诊断中的应用:临床实施中的创新工具。
Transl Neurodegener. 2024 Nov 21;13(1):56. doi: 10.1186/s40035-024-00449-2.
3
Liquid-liquid phase separation and conformational strains of -Synuclein: implications for Parkinson's disease pathogenesis.

本文引用的文献

1
Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis.通过实时无细胞免疫反应检测路易体痴呆中错误折叠的α-突触核蛋白:一项系统评价和荟萃分析
Front Mol Biosci. 2023 May 17;10:1193458. doi: 10.3389/fmolb.2023.1193458. eCollection 2023.
2
Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein.可溶性α-突触核蛋白的翻译后修饰调节病理性α-突触核蛋白的扩增。
Nat Neurosci. 2023 Feb;26(2):213-225. doi: 10.1038/s41593-022-01239-7. Epub 2023 Jan 23.
3
Cryo-EM of prion strains from the same genotype of host identifies conformational determinants.
α-突触核蛋白的液-液相分离和构象应变:对帕金森病发病机制的影响
Front Mol Neurosci. 2024 Oct 23;17:1494218. doi: 10.3389/fnmol.2024.1494218. eCollection 2024.
4
Parkinson's Disease Progression and Exposure to Contaminated Water at Camp Lejeune.帕金森病的进展与在勒琼营接触污染水。
Mov Disord. 2024 Oct;39(10):1732-1739. doi: 10.1002/mds.29922. Epub 2024 Jul 11.
5
Defining Parkinson's Disease: Past and Future.定义帕金森病:过去与未来。
J Parkinsons Dis. 2024;14(s2):S257-S271. doi: 10.3233/JPD-230411.
同种宿主来源的朊病毒株的低温电子显微镜分析确定构象决定因素。
PLoS Pathog. 2022 Nov 7;18(11):e1010947. doi: 10.1371/journal.ppat.1010947. eCollection 2022 Nov.
4
Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies.定量超分辨率成像病理性聚集体揭示不同神经核蛋白病的不同毒性特征。
Proc Natl Acad Sci U S A. 2022 Oct 11;119(41):e2205591119. doi: 10.1073/pnas.2205591119. Epub 2022 Oct 7.
5
Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein.患者匀浆扩增的α-突触核蛋白纤维的四聚体结构调节内源性α-突触核蛋白的种子形成。
Commun Biol. 2022 Sep 30;5(1):1040. doi: 10.1038/s42003-022-03948-y.
6
Structures of α-synuclein filaments from human brains with Lewy pathology.具有路易体病理的人脑α-突触核蛋白纤维的结构。
Nature. 2022 Oct;610(7933):791-795. doi: 10.1038/s41586-022-05319-3. Epub 2022 Sep 15.
7
α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders.α-突触核蛋白的分子行为和黑质蛋白质组特征可区分路易体疾病的亚型。
Acta Neuropathol. 2022 Aug;144(2):167-185. doi: 10.1007/s00401-022-02453-0. Epub 2022 Jun 24.
8
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.α-突触核蛋白 RT-QuIC 在路易体病神经病理分期中的表现。
Acta Neuropathol Commun. 2022 Jun 22;10(1):90. doi: 10.1186/s40478-022-01388-7.
9
Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.人源α-突触核蛋白转基因小鼠中的神经核蛋白病具有独特的播散特征和朊病毒样传播特性,且高度依赖宿主。
Acta Neuropathol. 2022 Jun;143(6):663-685. doi: 10.1007/s00401-022-02425-4. Epub 2022 Apr 30.
10
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.α-突触核蛋白在丝氨酸 129 的磷酸化发生在初始蛋白沉积之后,并抑制种子纤维形成和毒性。
Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2109617119. doi: 10.1073/pnas.2109617119. Epub 2022 Mar 30.